Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New York, New York 10035


Purpose:

Study hypothesis is that patients on antipsychotics medication treated with metformin will show loss in weight and improved measures of glucose metabolism.


Study summary:

Patients who had gained more than 10 lbs of weight in the last 3 months or had BMI of 35 or greater were treated with metformin up to 2500 mg/day in an open label study of up to 3 months time. Changes in weight and glucose measures were recorded.


Criteria:

Inclusion Criteria: - Patients will be 18-70 years of age; - Currently hospitalized or an outpatient at MPC; - BMI ≥ 35 or excessive recent weight gain ( > than 10 lb weight gain in the past 3 months); - Patients will have a diagnosis of schizophrenia or schizoaffective disorder or bipolar disorder. Exclusion Criteria: - Age below 18 or over 70; - Patient is currently already treated with metformin.


NCT ID:

NCT01177709


Primary Contact:

Principal Investigator
Robert C. Smith, MD PHD
Nathan Kline Institute for Psychiatric Research


Backup Contact:

N/A


Location Contact:

New York, New York 10035
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.